Regen BiopharmaRGBP
13F holders, Q1 2024 (March 31)1holders
$0.75avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Regen Biopharma Inc. (RGBP) in their 13F filings. The largest holder was Thompson Investment Management, Inc. ($3).
- Company
- Regen Biopharma Inc.
- CUSIP
- 75886M300
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Thompson Investment Management, Inc. | 0.00% | No change | 4 | $3 |
"% of holder's portfolio" is RGBP's weight in each manager's 13F, not the share of Regen Biopharma Inc. the manager owns.